| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |